Granulomatous Hepatitis Secondary to Carbamazepine

  1. MICHAEL LEVY, M. D.;
  2. MICHAEL W. GOODMAN, M.D.;
  3. BRUCE J. VAN DYNE, M.D.; and
  4. HATTON W. SUMNER, M.D.
  1. Minneapolis, Minnesota

    Abstract

    Three cases of carbamazepine-induced granulomatous hepatitis are reported. Each patient had ingested carbamazepine for less than 1 month before presenting with a febrile illness suggestive of biliary tract infection. After withdrawal of carbamazepine, symptoms disappeared rapidly. Histologically, all patients had granulomatous hepatitis. Two patients also had acute cholangitis. Carbamazepine-induced liver injury can be confused clinically and pathologically with biliary tract infection.

    Article and Author Information

    • ▸From the Department of Medicine, Hennepin County Medical Center, Department of Pathology, Veterans Administration Medical Center, and the University of Minnesota; Minneapolis, Minnesota.

    • ▸Requests for reprints should be addressed to Michael W. Goodman, M.D.; Department of Medicine, Hennepin County Medical Center, 701 Park Avenue South; Minneapolis, MN 55415.

    « Previous | Next Article »Table of Contents